Literature DB >> 14723877

Characterization of melatonin binding sites in the brain and retina of the frog Rana perezi.

Esther Isorna1, Ana Guijarro, María Jesús Delgado, Mercedes Alonso-Bedate, Angel L Alonso-Gómez.   

Abstract

The aim of this study was to characterize 2-[125I]iodomelatonin binding sites in the neural retina and central nervous system (telencephalon, diencephalon, and optic tectum) of the anuran amphibian Rana perezi. Saturation and kinetic studies and pharmacological characterization revealed the existence of a unique melatonin-binding site that belongs to the Mel 1 receptor subtype. The affinity of this site is similar in all tissues studied (Kd, 10.5-12.8 pM), but the density varied from diencephalon and optic tectum, which exhibit the highest density, to telencephalon with the lowest. Neural retina showed an intermediate receptor density. This melatonin-binding site fulfills the requirements of a real hormone receptor; the binding is saturable, reversible, and inhibited by different melatonin agonists and antagonists. The affinity order of ligands is: 2-phenyl-melatonin = 2-I-melatonin > 6-Cl-melatonin = melatoninz >> luzindole. Additionally, specific binding is decreased by non-hydrolysable GTP analogue, sodium, and by pretreatment of membranes with pertussis toxin. All these results suggest the existence of a widely distributed and pharmacologically homogeneous melatonin receptor of the subfamily Mel 1 in the nervous system of Rana perezi coupled to a Gi/o protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14723877     DOI: 10.1016/j.ygcen.2003.10.003

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  1 in total

1.  Ontogeny of central melatonin receptors in tadpoles of the anuran Rana perezi: modulation of dopamine release.

Authors:  Esther Isorna; Ana Isabel Guijarro; María Jesús Delgado; Marcos A López-Patiño; Nuria de Pedro; Angel Luis Alonso-Gómez
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2005-08-02       Impact factor: 1.836

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.